FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138867504> ?p ?o ?g. }

• W2138867504 endingPage "S413" @default.
• W2138867504 startingPage "S410" @default.
• W2138867504 abstract "The accelerated progression of atherosclerosis in diabetes is most probably the end result of the cumulative impact of the major risk factors that are more prevalent in diabetic subjects, namely obesity and dyslipidemia, the derangement in carbohydrate metabolism (hyperglycemic environment, hyperinsulinism, and insulin resistance), a prothrombotic tendency, and, perhaps most important, microalbuminuria and hypertension (1–5). At least two additional cardiovascular risk factors are probably more pronounced in diabetes; they are endothelial dysfunction (6) and an inflammatory reaction in the affected blood vessels mediated by the proinflammatory interleukins and expressed by elevated levels of C-reactive protein (7).Microalbuminuria is often the first clinical manifestation of early microvascular derangement. In type 2 diabetes, it is the hallmark of subsequent diabetic nephropathy and a surrogate marker of cardiovascular disease and increased cardiovascular mortality (8). Furthermore, the presence of microalbuminuria predicts a worse outcome after percutaneous coronary intervention. The 2-year mortality after percutaneous coronary intervention in diabetic patients with microalbuminuria was increased by 85% compared with individuals with normal urinary albumin excretion (9). Microalbuminuria is associated with echocardiographic evidence of left ventricular hypertrophy and identifies overall cardiovascular risk also in hypertensive nondiabetic patients (10,11). It is therefore mandatory to screen all diabetic as well as nondiabetic hypertensive patients for the presence of microalbuminuria. Indeed, all the relevant professional associations have included annual screening for microalbuminuria in their recommendations (12,13). Treatment strategies aimed at reducing urinary albumin excretion were found to be effective in retarding the progression of renal disease, as manifested by prolongation of the time to doubling of serum creatinine and postponement of end-stage renal disease and the need to renal replacement therapy (14–17).Furthermore, the magnitude of early decline in albuminuria in response to a given therapeutic intervention is a reliable predictor …" @default.
• W2138867504 created "2016-06-24" @default.
• W2138867504 creator A5057079800 @default.
• W2138867504 date "2009-10-29" @default.
• W2138867504 modified "2023-09-26" @default.
• W2138867504 title "Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy" @default.
• W2138867504 cites W180946569 @default.
• W2138867504 cites W1968834521 @default.
• W2138867504 cites W1984061204 @default.
• W2138867504 cites W1988124167 @default.
• W2138867504 cites W1997932141 @default.
• W2138867504 cites W2000812251 @default.
• W2138867504 cites W2002839070 @default.
• W2138867504 cites W2007063002 @default.
• W2138867504 cites W2007854458 @default.
• W2138867504 cites W2008494063 @default.
• W2138867504 cites W2009641798 @default.
• W2138867504 cites W2010912810 @default.
• W2138867504 cites W2011947902 @default.
• W2138867504 cites W2012387249 @default.
• W2138867504 cites W2017268330 @default.
• W2138867504 cites W2017686197 @default.
• W2138867504 cites W2018008593 @default.
• W2138867504 cites W2021011733 @default.
• W2138867504 cites W2044773944 @default.
• W2138867504 cites W2048242978 @default.
• W2138867504 cites W2049397775 @default.
• W2138867504 cites W2051035046 @default.
• W2138867504 cites W2056976690 @default.
• W2138867504 cites W2073282259 @default.
• W2138867504 cites W2073512707 @default.
• W2138867504 cites W2105325547 @default.
• W2138867504 cites W2107031719 @default.
• W2138867504 cites W2111119980 @default.
• W2138867504 cites W2112256909 @default.
• W2138867504 cites W2122340355 @default.
• W2138867504 cites W2126045082 @default.
• W2138867504 cites W2134726862 @default.
• W2138867504 cites W2136115956 @default.
• W2138867504 cites W2150045454 @default.
• W2138867504 cites W2152798629 @default.
• W2138867504 cites W2168482575 @default.
• W2138867504 cites W2312715682 @default.
• W2138867504 cites W2332330313 @default.
• W2138867504 cites W2003670762 @default.
• W2138867504 doi "https://doi.org/10.2337/dc09-s349" @default.
• W2138867504 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2811448" @default.
• W2138867504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19875590" @default.
• W2138867504 hasPublicationYear "2009" @default.
• W2138867504 type Work @default.
• W2138867504 sameAs 2138867504 @default.
• W2138867504 citedByCount "5" @default.
• W2138867504 countsByYear W21388675042015 @default.
• W2138867504 countsByYear W21388675042019 @default.
• W2138867504 countsByYear W21388675042021 @default.
• W2138867504 crossrefType "journal-article" @default.
• W2138867504 hasAuthorship W2138867504A5057079800 @default.
• W2138867504 hasBestOaLocation W21388675041 @default.
• W2138867504 hasConcept C126322002 @default.
• W2138867504 hasConcept C134018914 @default.
• W2138867504 hasConcept C170493617 @default.
• W2138867504 hasConcept C198710026 @default.
• W2138867504 hasConcept C2778468042 @default.
• W2138867504 hasConcept C2779922275 @default.
• W2138867504 hasConcept C2781184683 @default.
• W2138867504 hasConcept C555293320 @default.
• W2138867504 hasConcept C71924100 @default.
• W2138867504 hasConcept C84393581 @default.
• W2138867504 hasConceptScore W2138867504C126322002 @default.
• W2138867504 hasConceptScore W2138867504C134018914 @default.
• W2138867504 hasConceptScore W2138867504C170493617 @default.
• W2138867504 hasConceptScore W2138867504C198710026 @default.
• W2138867504 hasConceptScore W2138867504C2778468042 @default.
• W2138867504 hasConceptScore W2138867504C2779922275 @default.
• W2138867504 hasConceptScore W2138867504C2781184683 @default.
• W2138867504 hasConceptScore W2138867504C555293320 @default.
• W2138867504 hasConceptScore W2138867504C71924100 @default.
• W2138867504 hasConceptScore W2138867504C84393581 @default.
• W2138867504 hasIssue "suppl_2" @default.
• W2138867504 hasLocation W21388675041 @default.
• W2138867504 hasLocation W21388675042 @default.
• W2138867504 hasLocation W21388675043 @default.
• W2138867504 hasLocation W21388675044 @default.
• W2138867504 hasOpenAccess W2138867504 @default.
• W2138867504 hasPrimaryLocation W21388675041 @default.
• W2138867504 hasRelatedWork W1563850031 @default.
• W2138867504 hasRelatedWork W2038657938 @default.
• W2138867504 hasRelatedWork W2039838748 @default.
• W2138867504 hasRelatedWork W2044747643 @default.
• W2138867504 hasRelatedWork W2047608102 @default.
• W2138867504 hasRelatedWork W2052137618 @default.
• W2138867504 hasRelatedWork W2076513822 @default.
• W2138867504 hasRelatedWork W2077998387 @default.
• W2138867504 hasRelatedWork W2096973883 @default.
• W2138867504 hasRelatedWork W2126797993 @default.
• W2138867504 hasVolume "32" @default.
• W2138867504 isParatext "false" @default.
• W2138867504 isRetracted "false" @default.

• next